Document is current
Any future updates will be listed below
-
Authors
Sacha, Caitlin R. https://orcid.org/0000-0003-2170-1976
Nagykery, Nicholas
Meinsohn, Marie-Charlotte
Mattos, Karine de
Howard, James A.
Ramadan, Hadi
Minis, Evelyn
Zhang, LiHua
Fitz, Victoria
Hammer, Karissa
Souter, Irene C.
Thompson, Thomas B.
Donahoe, Patricia K.
Pépin, David https://orcid.org/0000-0003-2046-6708
-
Funding
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (1R01HD102014, R01HD105818)
New England Fertility Society Ferring Grant (ME-101649)
Surdna Foundation
- License Information
-
More Information
Article History
Received: 5 December 2024
Accepted: 27 May 2025
First Online: 17 June 2025
Declarations
:
: Our study was approved by the Massachusetts General Hospital Institutional Review Board (Protocol # 2007P001918). All patients signed an informed consent for the use of discarded follicular fluid for research purposes. All animal experiments were approved by the Institutional Animal Care and Use Committee (Protocol 2009N000033).
: D.P. and P.K.D. are the co-founders and scientific advisors of Oviva Therapeutics and hold equity. TT is a consultant for iBio Therapeutics, Catalym, and Third Rock Ventures. All authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
